Report on three additional patients and genotype-phenotype correlation in SLC25A22-related disorders group.
Journal
European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
received:
26
10
2018
accepted:
14
05
2019
revised:
06
05
2019
pubmed:
10
7
2019
medline:
21
7
2020
entrez:
10
7
2019
Statut:
ppublish
Résumé
Early infantile epileptic encephalopathy (EIEE) is a heterogeneous group of severe forms of age-related developmental and epileptic encephalopathies with onset during the first weeks or months of life. The interictal electroencephalogram (EEG) shows a "suppression burst" (SB) pattern. The prognosis is usually poor and most children die within the first two years or survive with very severe intellectual disabilities. EIEE type 3 is caused by variants affecting function, in SLC25A22, which is also responsible for epilepsy of infancy with migrating focal seizures (EIMFS). We report a family with a less severe phenotype of EIEE type 3. We performed exome sequencing and identified two unreported variants in SLC25A22 in the compound heterozygous state: NM_024698.4: c.[813_814delTG];[818 G>A] (p.[Ala272Glnfs*144];[Arg273Lys]). Functional studies in cultured skin fibroblasts from a patient showed that glutamate oxidation was strongly defective, based on a literature review. We clustered the 18 published patients (including those from this family) into three groups according to the severity of the SLC25A22-related disorders. In an attempt to identify genotype-phenotype correlations, we compared the variants according to the location depending on the protein domains. We observed that patients with two variants located in helical transmembrane domains presented a severe phenotype, whereas patients with at least one variant outside helical transmembrane domains presented a milder phenotype. These data are suggestive of a continuum of disorders related to SLC25A22 that could be called SLC25A22-related disorders. This might be a first clue to enable geneticists to outline a prognosis based on genetic molecular data regarding the SLC25A22 gene.
Identifiants
pubmed: 31285529
doi: 10.1038/s41431-019-0433-2
pii: 10.1038/s41431-019-0433-2
pmc: PMC6871179
doi:
Substances chimiques
Mitochondrial Membrane Transport Proteins
0
SLC25A22 protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1692-1700Références
J Inherit Metab Dis. 2017 May;40(3):385-394
pubmed: 28255779
Ann Neurol. 2013 Dec;74(6):873-82
pubmed: 24596948
J Biol Chem. 2002 May 31;277(22):19289-94
pubmed: 11897791
Clin Chim Acta. 1994 Jul;228(1):35-51
pubmed: 7955428
Epilepsia. 2017 Apr;58(4):512-521
pubmed: 28276062
J Clin Neurophysiol. 2003 Nov-Dec;20(6):398-407
pubmed: 14734930
J Physiol. 2006 May 1;572(Pt 3):789-98
pubmed: 16513670
Am J Hum Genet. 2005 Feb;76(2):334-9
pubmed: 15592994
J Exp Bot. 2001 Jan;52(354):37-45
pubmed: 11181711
Nat Neurosci. 2002 May;5(5):405-14
pubmed: 11953750
Eur J Hum Genet. 2016 Jul;24(7):992-1000
pubmed: 26626311
J Biol Chem. 1993 Sep 15;268(26):19369-76
pubmed: 8396136
Front Cell Neurosci. 2017 May 31;11:149
pubmed: 28620281
Clin Genet. 2009 Aug;76(2):188-94
pubmed: 19780765
J Neurosci Res. 2007 Nov 15;85(15):3367-77
pubmed: 17847082
Glia. 2017 Feb;65(2):401-415
pubmed: 27862359
Eur J Paediatr Neurol. 2014 Nov;18(6):801-5
pubmed: 25033742
Mol Aspects Med. 2013 Apr-Jun;34(2-3):465-84
pubmed: 23266187
Brain Res Dev Brain Res. 2003 Jun 12;143(1):33-46
pubmed: 12763579
Eur J Neurosci. 1997 Oct;9(10):2035-44
pubmed: 9421164